Statens Serum Institut

Grantee Website Copenhagen S., Denmark
Purpose
to develop an IPV vaccine adjuvanted with CAF01 that is able to promote significant dose-sparing and enhance mucosal immunity.
Division
Global Health
Date
OCTOBER 2012
Region Served
GLOBAL
Committed Amount
$158,739
Grant Topic
Discovery and Translational Sciences
Duration (Months)
28
Grantee Location
Copenhagen S., Denmark

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.